Factor IX Inhibitor Test | Lahalak Medical Platform
Essential test for Hemophilia B patients to detect antibodies hindering treatment efficacy, allowing doctors to adjust therapy for better bleeding control.
Scientific name: Factor IX Inhibitor Screening
Factor IX Inhibiting Antibody Screening is a functional laboratory test that detects the presence and activity of inhibitory antibodies directed against Factor IX in blood plasma. These inhibitors neutralize the effectiveness of exogenous Factor IX administered as therapy, leading to a lack of response to conventional treatment, a serious and criti...
Service type
Laboratory test (Blood)
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- A detailed analysis to diagnose the presence and measure the effectiveness of inhibitory antibodies to factor IX.
- Consult a hematologist to interpret the results.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- Fasting is not required, but it is preferable to draw the sample before the next dose of factor IX (at least 72 hours after the last therapeutic dose), to avoid interference with the therapeutic factor in the sample and to obtain an accurate result of the true inhibitor level.
- A blood sample is drawn into a tube containing citrate (blue tube).
- The laboratory must be informed of the date and time of the last dose of Factor IX received.
- The doctor may request a re-examination for confirmation if the result is positive for the first time.
Medical services you might also like
